Company*
(Country;
Symbol)

Company

Type/Product Area

Terms/Details (Date)


Artemis
Pharmaceuticals
GmbH
(Germany;
subsidiary of
Exelixis Inc.; EXEL)

Taconic Farms Inc.

Alliance for the generation and marketing of genetically engineered mice

The deal combines Artemis' leading technology in mouse genetics and genomics with Taconic's expertise in rodents; terms of the deal were not disclosed (6/20)

Geneva
Bioinformatics
SA*
(Switzerland)

KOOPrime Pte. Ltd. (Singapore)

KOOPrime will distribute GeneBio's Phenyx software platform in Singapore, Malaysia, China and Taiwan

The platform is used to identify and characterize proteins and peptides from mass spectrometry data; terms of the deal were not disclosed (6/22)

Palatin
Technologies
Inc.
(AMEX:PTN)

Competitive Technologies Inc. (AMEX:CTT)

They settled a dispute on a license agreement regarding certain peptides for treating sexual dysfunction

The technology-transfer company gets $1.7M in cash and 170,000 Palatin shares; Palatin and partner King Pharmaceuticals Inc. retain all rights to PT-141 (6/23)

Senomyx
Inc.
(SNMX)

Kraft Foods Global Inc.

They extended for two years a deal on flavor modifiers for a dessert product category and on an existing food and beverage product field

Senomyx gets discovery and development funding of $2.7M over the two-year extension period, and would get royalty payments on any resulting sales (7/29)

Senomyx
Inc.
(SNMX)

Cadbury Adams USA LLC

Deal for the discovery of new flavor ingredients in the gum confectionary area

Senomyx gets research funding and is entitled to milestone and royalty payments in the deal (7/18)


Notes:

* Private companies are indicated with an asterisk.

Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market.

AMEX = American Stock Exchange

No Comments